primary anti-adp-ribosylation antibody am80-100ug (Millipore)
Structured Review

Primary Anti Adp Ribosylation Antibody Am80 100ug, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/am80/anticd81+antibody++sab4700232+100ug+/pmc11467044-236-7-10
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "NAD + depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia"
Article Title: NAD + depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia
Journal: Life Science Alliance
doi: 10.26508/lsa.202302505
Figure Legend Snippet: (A, B, C) Gene expression of inflammatory markers in human placenta biopsies from all three PE subclasses (n = 4 placentas/group). (B, C) Representative immunofluorescence images and quantification of protein ADP-ribosylation in trophoblasts of human placental tissue sections from all three PE subclasses and various control groups (n = 7–8 placentas/group). ADP-ribosylation was measured specifically within the trophoblasts highlighted using the white lines. (D, E, F, G) LC/MS quantification of human placental NAD(H) levels (n = 15–42 placentas/group). (H) Heatmap of down-regulated mitochondrial proteins in inflammatory PE3 (term) placentas compared with control term placentas (n = 5–6 per group). Shown are only proteins that met the false discovery rate threshold of 0.05. (I, J) Placental oxidative stress was determined by immunofluorescence staining of human placental tissue sections with anti-8-oxo-dG antibody and quantification by the integrated intensity/area of trophoblasts (n = 4 per group). One-way ANOVA with Holm–Šídák’s multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. The error bar indicates the SD. Control = control term and preterm, CH = chronic hypertension control, PE1 = gestational parent–driven PE subclass, PE2 = hypoxia-driven PE subclass, PE3 = inflammation-driven PE subclass.
Techniques Used: Gene Expression, Immunofluorescence, Control, Liquid Chromatography with Mass Spectroscopy, Staining
Figure Legend Snippet: (A, B) Trophoblast protein ADP-ribosylation was determined by Western blot with anti-ADP-ribosylation antibody on cells treated with 10 ng/ml TNF-α and/or 150 μM–1 mM NR for 24 h (n = 3). One-way ANOVA with Holm–Šídák's multiple comparisons test. (C) Total cellular NAD + (H) and NAD + /NADH ratio quantification was performed on cells treated with or without 10 ng/ml TNF-α for 24 h (n = 3). One-tailed unpaired t test. (D, E, F, G) XFe96 Seahorse Mito stress test was performed on cells treated with 10 ng/ml TNF-α and/or 250 μM NR for 24 h. Basal, ATP-linked, and maximal mitochondrial respiration rates and extracellular acidification rates were measured (n = 4). (H, I, J, K, L) Expression of oxidative phosphorylation (OXPHOS) proteins was determined by Western blot with OXPHOS antibody cocktail on cells treated with 10 ng/ml TNF-α and/or 250 μM NR for 24 h (n = 4–7). (M, N) Trophoblast invasion capacity was determined by performing a Matrigel invasion assay on cells treated with 10 ng/ml TNF-α and/or 250 μM NR for 72 h (n = 3). Two-way ANOVA with Holm–Šídák's multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. The error bar indicates the SD. TNF-α = tumor necrosis factor, NR = nicotinamide riboside. Source data are available for this figure.
Techniques Used: Western Blot, One-tailed Test, Expressing, Phospho-proteomics, Invasion Assay
Figure Legend Snippet: (A) Placental TNF-α levels were determined by ELISA (n = 7–9 litters/treatment, 1 placenta/litter). (B, C) Placental protein ADP-ribosylation was determined by Western blot with anti-ADP-ribosylation antibody (n = 10 litters/treatment, 1 placenta/litter). (D) Placental ADP-ribose (ADPR) levels were determined by LC/MS (n = 6–10 litters/treatment, 1 placenta/litter). (E, F, G, H) Placental NAD + (H) levels were determined by a colorimetric assay (n = 8–10 litters/treatment, 1 placenta/litter). (I, J) Placental mitochondrial function was determined by performing an oxygraph assay on isolated mitochondria. Complex I– and complex II–mediated oxygen consumption rates were recorded to determine their activity (n = 4–8 litters/treatment, 6–8 placentas/litter). (K, L) Placental oxidative stress was determined by Western blot with anti-pH2A.X antibody, a marker of oxidative DNA damage (n = 7 litters/treatment, 1 placenta/litter). (M, N) Placental sections were stained with anti-pH2A.X antibody to determine the number of pH2A.X-positive cells in different regions of placenta (n = 5 litters/treatment, 1 placenta/litter). Two-way ANOVA with Holm–Šídák's multiple comparisons test, * P < 0.05, ** P < 0.01, *** P < 0.001. The error bar indicates the SD. ADPR = ADP-ribose, LPS = lipopolysaccharide, NR = nicotinamide riboside.
Techniques Used: Enzyme-linked Immunosorbent Assay, Western Blot, Liquid Chromatography with Mass Spectroscopy, Colorimetric Assay, Isolation, Activity Assay, Marker, Staining
